Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 25, 2021
has subject area
- 11 Medical and Health Sciences (FoR)
- Diabetes Mellitus, Type 2 (MeSH)
- General & Internal Medicine (Science Metrix)
- Glycated Hemoglobin (MeSH)
- Humans (MeSH)
- Hypoglycemic Agents (MeSH)
- Kidney (MeSH)
- Proline (MeSH)
published in
- New England Journal of Medicine Journal